Information for "Zotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial"

Jump to navigation Jump to search

Basic information

Display titleZotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial
Default sort keyZotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial
Page length (in bytes)2,850
Namespace ID0
Page ID77460
Page content languageen - English
Page content modelwikitext
Indexing by robotsAllowed
Number of redirects to this page0
Number of subpages of this page0 (0 redirects; 0 non-redirects)

Page protection

EditAllow all users (infinite)
MoveAllow all users (infinite)
View the protection log for this page.

Edit history

Total number of edits0
Recent number of edits (within past 30 days)0
Recent number of distinct authors0

Page properties

Magic word (1)
  • __NOTOC__
Transcluded templates (2)

Templates used on this page: